Cargando…

Adjuvant therapies for resected limited-stage small cell lung cancer

Detalles Bibliográficos
Autor principal: Lampridis, Savvas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390139/
https://www.ncbi.nlm.nih.gov/pubmed/36004158
http://dx.doi.org/10.1016/j.xjon.2021.05.018
_version_ 1784770586296188928
author Lampridis, Savvas
author_facet Lampridis, Savvas
author_sort Lampridis, Savvas
collection PubMed
description
format Online
Article
Text
id pubmed-9390139
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-93901392022-08-23 Adjuvant therapies for resected limited-stage small cell lung cancer Lampridis, Savvas JTCVS Open Thoracic: Lung Cancer: Letters to the Editor Elsevier 2021-06-17 /pmc/articles/PMC9390139/ /pubmed/36004158 http://dx.doi.org/10.1016/j.xjon.2021.05.018 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Thoracic: Lung Cancer: Letters to the Editor
Lampridis, Savvas
Adjuvant therapies for resected limited-stage small cell lung cancer
title Adjuvant therapies for resected limited-stage small cell lung cancer
title_full Adjuvant therapies for resected limited-stage small cell lung cancer
title_fullStr Adjuvant therapies for resected limited-stage small cell lung cancer
title_full_unstemmed Adjuvant therapies for resected limited-stage small cell lung cancer
title_short Adjuvant therapies for resected limited-stage small cell lung cancer
title_sort adjuvant therapies for resected limited-stage small cell lung cancer
topic Thoracic: Lung Cancer: Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390139/
https://www.ncbi.nlm.nih.gov/pubmed/36004158
http://dx.doi.org/10.1016/j.xjon.2021.05.018
work_keys_str_mv AT lampridissavvas adjuvanttherapiesforresectedlimitedstagesmallcelllungcancer